Document Classification

Section Type: RESULTS

Text: Treatment with R + FA resulted in a significantly higher proportion of patients achieving optimal levels of HDL-C (46. 8 % vs. 20. 8 %, P = 0. 009 for R 10 mg + FA), TG (60. 0 % vs. 34. 0 %, P = 0. 02 for R 10 mg + FA ; 54. 0 % vs. 26. 4 %, P = 0. 005 for R 20 mg + FA), non-HDL-C (55. 1 % vs. 36. 4 %, P = 0. 04 for R 5 mg + FA), ApoB (58. 0 % vs. 36. 4 %, P = 0. 02 for R 5 mg + FA) ; and the combined targets of LDL-C, HDL-C, and TG (28. 3 % vs. 8. 3 %, P = 0. 02 for R 10 mg + FA) and all 5 parameters (26. 1 % vs. 8. 3 %, P = 0. 03 for R 10 mg + FA) than corresponding-dose R monotherapies.